Mechanism of the attenuation of proteolysis-inducing factor stimulated protein degradation in muscle by β-hydroxy-β-methylbutyrate

Cancer Research

Volumn 64, Issue 23, 2004, Pages 8731-8735

  Smith, Helen J ^a   Wyke, Stacey M ^a   Tisdale, Michael J ^a  

^a ASTON UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; BETA HYDROXY BETA METHYL BUTYRATE; BUTYRIC ACID DERIVATIVE; I KAPPA B ALPHA; ICOSAPENTAENOIC ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LEUCINE; MEMBRANE PHOSPHOLIPID; MITOGEN ACTIVATED PROTEIN KINASE; PROTEASOME; PROTEIN KINASE C; PROTEIN P42; PROTEIN P44; PROTEOLYSIS INDUCING FACTOR; TUMOR PROTEIN; UBIQUITIN; UNCLASSIFIED DRUG;

ALPHA CHAIN; ANIMAL CELL; ARTICLE; BETA CHAIN; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVATION; GENE EXPRESSION; IN VITRO STUDY; MOUSE; MYOTUBE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; WEIGHT REDUCTION;

ANIMALS; ARACHIDONIC ACID; BLOOD PROTEINS; DISEASE MODELS, ANIMAL; EICOSAPENTAENOIC ACID; MICE; MUSCLE FIBERS; MUSCLE PROTEINS; NEOPLASMS, EXPERIMENTAL; PROTEASOME ENDOPEPTIDASE COMPLEX; SIGNAL TRANSDUCTION; UBIQUITIN; VALERATES; WEIGHT LOSS;

EID: 9244227105     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-04-1760     Document Type: Article

References (33)

1. Baracos VE. Management of muscle wasting in cancer-associated cachexia. Cancer 2001;92:1669-77.
2. Barber MD, Ross JA, Voss AC, Tisdale MJ, Fearon KCH. The effect of an oral nutritional supplement enriched with fish oil on weight-loss in patients with pancreatic cancer. Br J Cancer 1999;81:80-6.
3. Bossola M, Muscaritoli M, Costelli P, et al. Increased muscle proteasome activity correlates with disease severity in gastric cancer patients. Ann Surgery 2003;237:384-9.
4. Llovera M, Garcia-Martinez C, Agell N, Lopez-Soriano FJ, Argiles JM. TNF can directly induce the expression of ubiquitin-dependent proteolytic system in rat soleus muscles. Biochem Biophys Res Commun 1997;230:238-41.
5. Mulligan HD, Mahony SM, Ross JA, Tisdale MJ. Weight loss in a murine cachexia model is not associated with the cytokines tumour necrosis factor-α or interleukin-6. Cancer Lett 1992;65:239-43.
6. Lorite MJ, Thompson MG, Drake JL, Carling G, Tisdale MJ. Mechanism of muscle protein degradation induced by a cancer cachectic factor. Br J Cancer 1998;78:850-6.
7. Lorite MJ, Smith HJ, Arnold JA, Morris A, Thompson MG, Tisdale MJ. Activation of ATP-ubiquitin-dependent proteolysis in skeletal muscle in vivo and murine myoblasts in vitro by a proteolysis-inducing factor (PIF). Br J Cancer 2001;85:297-302.
8. Wang Z, Corey E, Hass GM, et al. Expression of the human cachexia-associated protein (HCAP) in prostate cancer and in a prostate cancer animal model of cachexia. Int J Cancer 2003;105:123-9.
9. Cabal-Manzano R, Bhargava P, Torres-Duatte A, Marshall J, Bhargava P, Wainer IW. Proteolysis-inducing factor is expressed in tumours of patients with gastrointestinal cancers and correlates with weight loss. Br J Cancer 2001;84:1599-601.
10. 12 myoblasts: modulation by eicosapentaenoic acid. Cancer Res 1999;59:5507-13.
11. Whitehouse AS, Smith HJ, Drake JL, Tisdale MJ. Mechanism of attenuation of skeletal muscle protein catabolism in cancer cachexia by eicosapentaenoic acid. Cancer Res 2001;61:3604-9.
12. Whitehouse AS, Khal J, Tisdale MJ. Induction of protein catabolism in myotubes by 15(S)-hydroxyeicosatetraenoic acid through increased expression of the ubiquitin-proteasome pathway. Br J Cancer 2003;89:737-45.
13. Whitehouse AS, Tisdale MJ. Increased expression of the ubiquitin-proteasome pathway in murine myotubes by proteolysis-inducing factor (PIF) is associated with activation of the transcription factor NF-κB. Br J Cancer 2003;89:1116-22.
14. 12 myotubes. Br J Cancer 2004;90:1850-7.
15. Todorov P, Cariuk P, McDevitt T, Coles B, Fearon KCH, Tisdale M. Characterization of a cancer cachectic factor. Nature 1996;379:739-42.
16. Todorov P, McDevitt TM, Cariuk P, Coles B, Deacon M, Tisdale MJ. Induction of muscle protein degradation and weight loss by a tumor product. Cancer Res 1996;56:1256-61.
17. Orino E, Tanaka K, Tamura T, Sone S, Ogura T, Ichihara A. ATP-dependent reversible association of proteasomes with multiple protein components to form 26S complexes that degrade ubiquitinated proteins in human HL-60 cells. FEBS Lett 1991;284:206-10.
18. Fenteany G, Schreiber SL. Lactacystin, proteasome function and cell fate. J Biol Chem 1998;273:8545-8.
19. Andrews NC, Faller DV. A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucleic Acids Res 1991;19:2499.
20. Tanahashi N, Kawahara H, Murakami Y, Tanaka K. The proteasome-dependent proteolytic system. Mol Biol Rep 1999;26:3-9.
21. Toker A. Signaling through protein kinase C. Front Biosci 1998;3:1134-47.
22. Smith HJ, Tisdale MJ. Signal transduction pathways involved in proteolysis-inducing factor induced proteasome expression in murine myotubes. Br J Cancer 2003;89:1783-8.
23. Nissen SL, Abumrad NN. Nutritional role of the leucine metabolite β-hydroxy β-methylbutyrate (HMB). J Nutr Biochem 1997;8:300-11.
24. May PE, Barber A, D'Olimpio JT, Hourihane A, Abumrad NN. Reversal of cancer-related wasting using oral supplementation with a combination of β-hydroxy-β-methylbutyrate, arginine and glutamine. Am J Surg 2002;183:471-9.
25. Clark RH, Feleke G, Din M, et al. Nutritional treatment for acquired immunodeficiency virus-associated wasting using β-hydroxy β-methylbutyrate, glutamine, and arginine: a randomised, double-blind, placebo-controlled study. J Parenter Enteral Nutr 2000;24:133-9.
26. Gomes-Marcondes MCC, Smith HJ, Cooper JC, Tisdale MJ. Development of an in-vitro model system to investigate the mechanism of muscle protein catabolism induced by proteolysis-inducing factor. Br J Cancer 2002;86:1628-33.
27. Whitehouse AS, Tisdale MJ. Downregulation of ubiquitin-dependent proteolysis by eicosapentaenoic acid in acute starvation. Biochem Biophys Res Commun 2001;285:598-602.
28. Fan X, Hunag X, DaSilva C, Castanga M. Arachidonic acid and related methyl ester mediate protein kinase C activation in intact platelets through the arachidonate metabolism pathways. Biochem Biophys Res Commun 1990;109:933-40.
29. Vertegaal ACO, Kuiperij HB, Yamaoka S, Courtois G, Van der Eb AJ, Zantema A. Protein kinase C-α is an upstream activator of the IκB kinase complex in the TPA signal transduction pathway to NF-κB in U20S cells. Cell Sig 2000;12:759-68.
30. Chang L, Karin M. Mammalian MAP kinase signalling cascades. Nature 2001;410:37-40.
31. Blumer KJ, Johnson GL. Diversity in function and regulation of MAP kinase cascade 1 pathway. Trends Biochem Sci 1994;19:236-40.
32. Burgering BMT, Bos JL. Regulation of Ras-mediated signalling: more than one way to skin a cat. Trends Biochem Sci 1995;20:18-22.
33. Kolch W, Heidecker G, Kochs G, et al. Protein kinase C α activates Raf-1 by direct phosphorylation. Nature 1993;364:249-52.